The management of epithelial ovarian cancer: neoadjuvant chemotherapy and interval surgery
Keywords: Ovarian cancer, Neoadjuvant chemotherapy, interval surgery
AbstractOvarian cancer is the fourth most common cause of death from cancer in women and remains a significant problem. Treatment continues to be difficult as most women have advanced stage cancers at presentation. Some progress in terms of management and survival has been made in the last 20 years, but the mortality rate remains high. Improving outcomes in terms of mortality and quality of life will rely on a better understanding of the aetiology, effective population screening and increased management options.
By submitting manuscripts to SAJGO, authors of original articles are assigning copyright to the South African Society of Gynaecologic Oncology (SASGO). Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAJGO for educational and research purposes without obtaining permission.